Related Experiment Video
Updated: Mar 6, 2026
Modified Single-Loop Reconstruction for Pancreaticoduodenectomy
Published on: September 28, 2019
Minimally invasive pancreatoduodenectomy
Michael L Kendrick1, Jony van Hilst2, Ugo Boggi3
1Mayo Clinic, Rochester, MN, USA.
Background:
Minimally invasive pancreatoduodenectomy (MIPD) is increasingly performed with several institutional series and comparative studies reported. The aim was to conduct an assessment of the best-evidence and expert opinion on the current status and future challenges of MIPD.
Methods:
A systematic review of the literature was performed and best-evidence presented at a State-of-the-Art conference on Minimally Invasive Pancreatic Resection. Expert panel discussion and audience response activity was used to assess perceived value and future direction.
Results:
From 582 studies, 26 comparative trials of MIPD and open pancreatoduodenectomy (OPD) were assessed for perioperative outcomes. There were no randomized controlled trials and all available comparative studies were determined of low quality. Several observational and case-matched studies demonstrate longer operative times, but less estimated blood loss and shorter length of hospital stay for MIPD. Registry-based studies demonstrate increased mortality rates after MIPD in low-volume centers. Oncologic assessment demonstrates comparable outcomes of MIPD. Expert opinion supports ongoing evaluation of MIPD.
Conclusion:
MIPD appears to provide similar perioperative and oncologic outcomes in selected patients, when performed at experienced, high-volume centers. Its overall role in pancreatoduodenectomy needs to be better defined. Improved training opportunities, registry participation and prospective evaluation are needed.
Insights
Minimally invasive pancreatoduodenectomy (MIPD) shows comparable outcomes to open surgery in select patients at high-volume centers. Further research and training are essential to define its role and improve patient safety.
Area of Science:
- Surgical Oncology
- Gastroenterology
- Minimally Invasive Surgery
Background:
- Minimally invasive pancreatoduodenectomy (MIPD) is gaining traction, with numerous studies and institutional reports available.
- Assessing the current evidence and expert consensus on MIPD is crucial for understanding its role and future challenges.
Purpose of the Study:
- To evaluate the best available evidence and expert opinions regarding the current status of MIPD.
- To identify future challenges and research needs for minimally invasive pancreatoduodenectomy.
Main Methods:
- A systematic literature review was conducted, focusing on comparative trials of MIPD versus open pancreatoduodenectomy (OPD).
- Evidence was presented at a State-of-the-Art conference, supplemented by expert panel discussions and audience feedback.
Main Results:
- 26 comparative studies of low quality were assessed; no randomized controlled trials were identified.
- MIPD demonstrated longer operative times, reduced blood loss, and shorter hospital stays compared to OPD.
- Registry data indicated higher mortality for MIPD in low-volume centers, while oncologic outcomes were comparable.
- Expert opinion favored continued evaluation of MIPD.
Conclusions:
- MIPD offers similar perioperative and oncologic outcomes to OPD in carefully selected patients at high-volume, experienced centers.
- The precise role of MIPD in pancreatic surgery requires further definition.
- Enhanced training, registry participation, and prospective studies are necessary to advance MIPD.
More Related Videos
Related Concept Videos
01:26Endoscopic Procedures V: ERCP
Patient...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment: